5-methoxytryptophan alleviates liver fibrosis by modulating FOXO3a/miR-21/ATG5 signaling pathway mediated autophagy

References

• Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38–53.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6(1):425–456.
   PubMedGoogle Scholar
• Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013;123(5):1887–1901.
   PubMed Web of Science ®Google Scholar
• Yin C, Evason KJ, Asahina K, et al. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123(5):1902–1910.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275(4):2247–2250.
   PubMed Web of Science ®Google Scholar
• Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis. 2001; 21(3):397–416.
   Google Scholar
• Cheng HH, Kuo CC, Yan JL, et al. Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan. Proc Natl Acad Sci U S A. 2012;109(5):13231–13236.
   Google Scholar
• Wu KK, Cheng HH, Chang TC. 5-methoxyindole metabolites of L-tryptophan: control of COX-2 expression, inflammation and tumorigenesis. J Biomed Sci. 2014;21(1):17.
   PubMedGoogle Scholar
• Flight WF, Mans D, Balemans MG. Methoxyindole synthesis in the retina of the frog (Rana esculenta) during a diurnal period. J Neural Transm. 1983;58(3–4):223–230.
   PubMed Web of Science ®Google Scholar
• Chou HC, Chan HL. 5-Methoxytryptophan-dependent protection of cardiomyocytes from heart ischemia reperfusion injury. Arch Biochem Biophys. 2014;543:15–22.
   PubMed Web of Science ®Google Scholar
• Chen DQ, Cao G, Chen H, et al. Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan. Nat Commun. 2019;10(1):1476. .
   PubMedGoogle Scholar
• Chang TC, Hsu MF, Shih CY, et al. 5-methoxytryptophan protects MSCs from stress induced premature senescence by upregulating FoxO3a and mTOR. Sci Rep. 2017;7(1):11133.
   PubMedGoogle Scholar
• Wang K, Li PF. Foxo3a regulates apoptosis by negatively targeting miR-21. J Biol Chem. 2010;285(22):16958–16966.
   PubMed Web of Science ®Google Scholar
• Wu K, Ye C, Lin L, et al. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clin Sci. 2016;130(16):1469–1480.
   Web of Science ®Google Scholar
• Yang F, Luo L, Zhu ZD, et al. Chlorogenic acid inhibits liver fibrosis by blocking the miR-21-regulated TGF-beta1/Smad7 signaling pathway in vitro and in vivo. Front Pharmacol. 2017;8:929.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290(5497):1717–1721.
   PubMed Web of Science ®Google Scholar
• Hidvegi T, Ewing M, Hale P, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science. 2010;329(5988):229–232.
   PubMed Web of Science ®Google Scholar
• Liu H, Mi S, Li Z, et al. Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells. Autophagy. 2013;9(5):730–742.
   PubMed Web of Science ®Google Scholar
• Mi S, Li Z, Yang HZ, et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Iimmunol. 2011;187(6):3003–3014. .
   PubMed Web of Science ®Google Scholar
• Zhang XW, Zhou JC, Peng D, et al. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy. 2020;16(5):782–796.
   Google Scholar
• Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27(1):107–132.
   PubMed Web of Science ®Google Scholar
• Tekirdag KA, Korkmaz G, Ozturk DG, et al. MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5. Autophagy. 2013;9(3):374–385.
   PubMed Web of Science ®Google Scholar
• Szak ST, Mays D, Pietenpol JA. Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol. 2001;21(10):3375–3386.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang S, Xie Y, et al. Effect of salvianolic acid B and paeonol on blood lipid metabolism and hemorrheology in myocardial ischemia rabbits induced by pituitruin. Int J Mol Sci. 2010;11(10):3696–3704.
   PubMed Web of Science ®Google Scholar
• Wang YF, Hsu YJ, Wu HF, et al. Endothelium-derived 5-methoxytryptophan is a circulating anti-inflammatory molecule that blocks systemic inflammation. Circ Res. 2016;119(2):222–236. .
   PubMed Web of Science ®Google Scholar
• Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215.
   PubMed Web of Science ®Google Scholar
• Cianfanelli V, Fuoco C, Lorente M, et al. AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation. Nat Cell Biol. 2015;17(1):20–30.
   PubMed Web of Science ®Google Scholar
• Lam KK, Zheng X, Forestieri R, et al. Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathog. 2012;8(5):e1002691. .
   PubMed Web of Science ®Google Scholar
• Phadwal K, Watson AS, Simon AK. Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging. Cell Mol Life Sci. 2013;70(1):89–103.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. Autophagy fuels tissue fibrogenesis. Autophagy. 2012;8(5):849–850.
   PubMed Web of Science ®Google Scholar
• Thoen LF, Guimaraes EL, Dolle L, et al. A role for autophagy during hepatic stellate cell activation. J Hepatol. 2011;55(6):1353–1360.
   PubMed Web of Science ®Google Scholar
• Webb AE, Brunet A. FOXO transcription factors: key regulators of cellular quality control. Trends Biochem Sci. 2014;39(4):159–169.
   PubMed Web of Science ®Google Scholar
• Kumazoe M, Takai M, Bae J, et al. FOXO3 is essential for CD44 expression in pancreatic cancer cells. Oncogene. 2017;36(19):2643–2654. .
   PubMed Web of Science ®Google Scholar
• O’Neill BT, Lee KY, Klaus K, et al. Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. J Clin Invest. 2016;126(9):3433–3446.
   PubMed Web of Science ®Google Scholar
• Kim DH, Park MH, Lee EK, et al. The roles of FoxOs in modulation of aging by calorie restriction. Biogerontology. 2015;16(1):1–14.
   PubMed Web of Science ®Google Scholar
• Page A, Paoli PP, Hill SJ, et al. Alcohol directly stimulates epigenetic modifications in hepatic stellate cells. J Hepatol. 2015;62(2):388–397.
   PubMed Web of Science ®Google Scholar
• Amabile G, Di Ruscio A, Muller F, et al. Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun. 2015;6(1):7091.
   PubMedGoogle Scholar
• Park SJ, Sohn HY, Yoon J, et al. Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activated hepatic stellate cells. Cell Signal. 2009;21(10):1495–1503.
   PubMed Web of Science ®Google Scholar
• Jiang X, Tsitsiou E, Herrick SE, et al. MicroRNAs and the regulation of fibrosis. Febs J. 2010;277(9):2015–2021.
   PubMed Web of Science ®Google Scholar
• Liang C, Bu S, Fan X. Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-beta1/Smad3. Cell Biochem Funct. 2016;34(5):326–333.
   PubMed Web of Science ®Google Scholar
• Yan G, Li B, Xin X, et al. MicroRNA-34a promotes hepatic stellate cell activation via targeting ACSL1. Med Sci Monit. 2015;21:3008–3015.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zha Y, Hu W, et al. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem. 2013;288(52):37082–37093.
   PubMed Web of Science ®Google Scholar
• Zhao J, Tang N, Wu K, et al. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PloS One. 2014;9(10):e108005.
   PubMed Web of Science ®Google Scholar